Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5394-36-5

Post Buying Request

5394-36-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5394-36-5 Usage

Uses

Reactant for synthesis of nociceptin/orphanin FQ analogues

Check Digit Verification of cas no

The CAS Registry Mumber 5394-36-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,9 and 4 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5394-36:
(6*5)+(5*3)+(4*9)+(3*4)+(2*3)+(1*6)=105
105 % 10 = 5
So 5394-36-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H10N2O2/c1-3-6(2)4(9)7-5(10)8-6/h3H2,1-2H3,(H2,7,8,9,10)

5394-36-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (454273)  5-Ethyl-5-methylhydantoin  97%

  • 5394-36-5

  • 454273-1G

  • 431.73CNY

  • Detail

5394-36-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-Imidazolidinedione,5-ethyl-5-methyl-

1.2 Other means of identification

Product number -
Other names 5-methyl-5-ethylhydantoin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Ion exchange agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5394-36-5 SDS

5394-36-5Synthetic route

tetra-n-butylammonium cyanide
10442-39-4

tetra-n-butylammonium cyanide

ammonium carbonate
506-87-6

ammonium carbonate

butanone
78-93-3

butanone

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
In ethanol; water for 40h; Heating;50%
(1-cyano-1-methyl-propyl)-urea

(1-cyano-1-methyl-propyl)-urea

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With hydrogenchloride
2-amino-2-methylbutanenitrile
4475-95-0

2-amino-2-methylbutanenitrile

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With carbon dioxide; water
2-hydroxy-2-methyl-butyronitrile
4111-08-4

2-hydroxy-2-methyl-butyronitrile

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With ammonium carbonate at 90℃;
2-cyano-2-methyl-butyric acid amide

2-cyano-2-methyl-butyric acid amide

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With potassium hypobromite inactive form;
N-(2-amino-2-methyl-butyryl)-N'-(3,5-diethyl-2-imino-5-methyl-pyrrolidin-3-yl)-urea

N-(2-amino-2-methyl-butyryl)-N'-(3,5-diethyl-2-imino-5-methyl-pyrrolidin-3-yl)-urea

A

3,5-diethyl-2-imino-5-methyl-pyrrolidin-3-ylamine
98957-58-5

3,5-diethyl-2-imino-5-methyl-pyrrolidin-3-ylamine

B

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With hydrogenchloride
hydrogen cyanide
74-90-8

hydrogen cyanide

butanone
78-93-3

butanone

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
beim Belichten; inactive form;
2-amino-2-methylbutanenitrile
4475-95-0

2-amino-2-methylbutanenitrile

2CO3

2CO3

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With water
potassium cyanide
151-50-8

potassium cyanide

butanone
78-93-3

butanone

2CO3

2CO3

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With ethanol
potassium cyanate
590-28-3

potassium cyanate

l-isovaline

l-isovaline

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
Abdampfen des entstandenen Harnstoffderivats mit verd. Salzsaeure; active form;
butanone
78-93-3

butanone

aluminium oxide

aluminium oxide

A

2-amino-2-methylbutanenitrile
4475-95-0

2-amino-2-methylbutanenitrile

B

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
at 350℃;
at 350 - 360℃;
2-hydroxy-2-methyl-butyronitrile
4111-08-4

2-hydroxy-2-methyl-butyronitrile

ammonium carbonate
506-87-6

ammonium carbonate

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
Heating / reflux;
potassium cyanide

potassium cyanide

ammonium carbonate
506-87-6

ammonium carbonate

butanone
78-93-3

butanone

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
Stage #1: butanone With sodium metabisulfite
Stage #2: potassium cyanide Bucherer-Bergs reaction;
Stage #3: ammonium carbonate Bucherer-Bergs reaction;
methyloxirane
75-56-9, 16033-71-9

methyloxirane

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

5-ethyl-1,3-bis-(2-hydroxy-propyl)-5-methyl-imidazolidine-2,4-dione
29810-32-0

5-ethyl-1,3-bis-(2-hydroxy-propyl)-5-methyl-imidazolidine-2,4-dione

Conditions
ConditionsYield
With hydrogenchloride; lithium chloride In N-methyl-acetamide99.5%
4-chlorobutyl bromide
6940-78-9

4-chlorobutyl bromide

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

3-(4-chlorobutyl)-5-ethyl-5-methylimidazolidine-2,4-dione

3-(4-chlorobutyl)-5-ethyl-5-methylimidazolidine-2,4-dione

Conditions
ConditionsYield
With potassium hydroxide In ethanol for 15h; Heating;81%
iodobenzene
591-50-4

iodobenzene

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

5-ethyl-5-methyl-3-phenylhydantoin
36027-16-4

5-ethyl-5-methyl-3-phenylhydantoin

Conditions
ConditionsYield
With copper(I) oxide In N,N-dimethyl-formamide at 150℃; for 14h; Inert atmosphere; regioselective reaction;68%
5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

methyl iodide
74-88-4

methyl iodide

5-ethyl-3,5-dimethyl-imidazolidine-2,4-dione
6843-47-6

5-ethyl-3,5-dimethyl-imidazolidine-2,4-dione

Conditions
ConditionsYield
With potassium hydroxide; ethanol
5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

DL-isovaline
595-39-1

DL-isovaline

Conditions
ConditionsYield
With barium dihydroxide Heating;
(hydrolysis);
With barium hydroxide octahydrate; water at 140℃; for 48h;
5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

methyl iodide
74-88-4

methyl iodide

5-ethyl-1,3,5-trimethylhydantoin

5-ethyl-1,3,5-trimethylhydantoin

Conditions
ConditionsYield
With pH 13 buffer
hydrogenchloride
7647-01-0

hydrogenchloride

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

DL-isovaline
595-39-1

DL-isovaline

Conditions
ConditionsYield
im Rohr; inactive form;
5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

3-{4-[Bis-(2-chloro-ethyl)-amino]-butyl}-5-ethyl-5-methyl-imidazolidine-2,4-dione

3-{4-[Bis-(2-chloro-ethyl)-amino]-butyl}-5-ethyl-5-methyl-imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 81 percent / KOH / aq. ethanol / 15 h / Heating
2: 68 percent
3: 28 percent / POCl3
View Scheme
5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

3-{4-[Bis-(2-hydroxy-ethyl)-amino]-butyl}-5-ethyl-5-methyl-imidazolidine-2,4-dione

3-{4-[Bis-(2-hydroxy-ethyl)-amino]-butyl}-5-ethyl-5-methyl-imidazolidine-2,4-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 81 percent / KOH / aq. ethanol / 15 h / Heating
2: 68 percent
View Scheme
active charcoal

active charcoal

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

3-[2-(Vinyloxy)-ethyl]-5-methyl-5-ethyl-hydantoin
69850-89-1

3-[2-(Vinyloxy)-ethyl]-5-methyl-5-ethyl-hydantoin

Conditions
ConditionsYield
With potassium carbonate In N-methyl-acetamide; acetone
iodobenzene
591-50-4

iodobenzene

5-ethyl-5-methylimidazolidine-2,4-dione
5394-36-5

5-ethyl-5-methylimidazolidine-2,4-dione

5-ethyl-5-methyl-1,3-diphenylhydantoin

5-ethyl-5-methyl-1,3-diphenylhydantoin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: copper(I) oxide / N,N-dimethyl-formamide / 14 h / 150 °C / Inert atmosphere
2: copper(l) iodide; potassium carbonate; trans-N,N'-dimethylcyclohexane-1,2-diamine / toluene / 48 h / 110 °C / Inert atmosphere
View Scheme

5394-36-5Relevant articles and documents

AMIDOALKYLPIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

-

Page/Page column 29; 30, (2013/03/26)

The invention relates to novel amidoalkylpiperazinyl derivatives of tricyclic heterocyclic systems of general formula (I), wherein Z represents -NH- and X represents -S-, or Z represents -S- and X represents >C=C1 represents H or -CH3, R6 and R7 both represent H, n is an integer from 0 to 4 inclusive, G represents a cyclic amide or imide moiety, and optical isomers, geometric isomers, and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of the central nervous system disorders.

New polyamides based on 1,3-bis(4-carboxy phenoxy) propane and hydantoin derivatives: Synthesis and properties

Faghihi, Khalil,Valikhani, Nasim

experimental part, p. 77 - 83 (2010/12/19)

Six new polyamides 5a-f containing flexible trimethylene segments in the main chain were synthesized through the direct polycondensation reaction of 1,3-bis(4-carboxy phenoxy) propane 3 with six derivatives of hydantoins 4a-f in a medium consisting of N-methyl-2-pyrrolidone, triphenyl phosphite, calcium chloride and pyridine. The polycondensation reaction produced a series of novel polyamides in high yield with inherent viscosities between 0.30-0.47 dL/g. The resulted polymers were fully characterized by means of FT-IR, 1H-NMR spectroscopy, elemental analyses, inherent viscosity, solubility tests and gel permeation chromatography (GPC). Thermal properties of these polymers were investigated by using thermal gravimetric analysis (TGA) and differential thermal gravimetry (DTG). The glass-transition temperatures of these polyamides were recorded between 130 and 155 °C by differential scanning catorimetry (DSC), and the 5% weight loss temperatures were ranging from 325 to 415 °C under nitrogen. 1,3-bis(4-Carboxy phenoxy) propane 3 was prepared from the reaction of 4-hydroxy benzoic acid 1 with 1,3-dibromo propane 2 in the presence of NaOH solution.

Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids

Arduin, Marika,Spagnolo, Barbara,Calo, Girolamo,Guerrini, Remo,Carra, Giacomo,Fischetti, Carmela,Trapella, Claudio,Marzola, Erika,McDonald, John,Lambert, David G.,Regoli, Domenico,Salvadori, Severo

, p. 4434 - 4443 (2008/03/13)

Previous structure-activity and NMR studies on nociceptin/orphanin FQ (N/OFQ) demonstrated that Aib substitution of Ala7 and/or Ala11 increases the peptide potency through an alpha helix structure induction mechanism. On these bases we synthesised and evaluated pharmacologically in the mouse vas deferens assay a series of N/OFQ-NH2 analogues substituted in position 7 and 11 with Cα,α-disubstituted cyclic, linear and branched amino acids. None of the 20 novel N/OFQ analogues produced better results than [Aib7]N/OFQ-NH2. Thus, this substitution was combined with other chemical modifications known to modulate peptide potency and/or efficacy generating compound 21 [Nphe1Aib7Arg14Lys15]N/OFQ-NH2 (coded as UFP-111), compound 22 [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-112) and compound 23 [Phe1Ψ(CH2-NH)Gly2(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-113). These novel peptides behaved as highly potent NOP receptor ligands showing full (UFP-112) and partial (UFP-113) agonist and pure antagonist (UFP-111) activities in a series of in vitro functional assays performed on pharmacological preparations expressing native as well as recombinant NOP receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5394-36-5